Cancer Health Treatment Update Counties With Persistent Poverty Rates Have Higher Rates of Cancer Death For each cancer type studied, mortality was between 11% and 50% higher in the counties with persistent poverty. Immunotherapy-Chemotherapy Combo Beneficial In Triple-Negative Breast Cancer Adding Tecentriq to a three-drug chemotherapy regimen increases odds of remission of early-stage triple-negative breast cancer. Researchers Win Nobel Prize for Hepatitis C Discovery The blood-borne virus, which can lead to cirrhosis and liver cancer, remains a major global health threat. Padcev Improves Overall Survival in People With Bladder Cancer The antibody-drug conjugate improved overall survival by 30% in comparison with chemotherapy in a Phase III clinical trial. News From the ESMO Virtual Congress See all our reports from Europe's biggest cancer conference. Black Doctors Create a COVID-19 Vaccine Assessment Task Force The panel’s goal is to ensure that all coronavirus therapeutics approved by the government are safe and effective for African Americans. More News About COVID-19 See all Cancer Health coverage of COVID-19, including how it affects people living with cancer. For other news about the new coronavirus, visit COVID Health. Cancer Health Fall 2020 Check out our latest print edition! Advertisement Newsfeed Researchers Win Nobel Prize for Hepatitis C Discovery How Lifestyle Factors Affect Breast Cancer Risk Eddie Van Halen Has Died of Throat Cancer Counties With Persistent Poverty Rates Have Higher Rates of Cancer Death Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma Newsfeed Researchers Win Nobel Prize for Hepatitis C Discovery How Lifestyle Factors Affect Breast Cancer Risk Eddie Van Halen Has Died of Throat Cancer Counties With Persistent Poverty Rates Have Higher Rates of Cancer Death Blog: Food and Drug Administration (FDA) FDA Issues Alert About Tecentriq Plus Paclitaxel for Breast Cancer FDA Approves Onureg for Acute Myeloid Leukemia FDA Updates Analysis of Medical Device Reports of Breast Implant Illness and Breast Implant-Associated Lymphoma FDA approves Kyprolis Plus Darzalex Combination for Multiple Myeloma

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: